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Abstract
Volumetric imaging (VOL), a three-dimensional magnetic resonance imaging (MRI) technique, has
been described in the literature for evaluation of the human brain. It offers several advantages
over conventional two-dimensional (2D) spin echo (SE), allowing rapid, whole-brain, isotropic
imaging with submillimeter voxels. This retrospective, observational study compares the use of
2D T1-weighted SE (T1W SE), with T1W VOL, for the evaluation of dogs with clinical signs of
intracranial disease. Brain MRI images from 160 dogs who had T1W SE and T1WVOL sequences
acquired pre- and postcontrast, were reviewed for presence and characteristics of intracranial
lesions. Twenty-nine of 160 patients were found to have intracranial lesions, all visible on both
sequences. Significantly better grey-whitematter (GWM)differentiationwas identifiedwith T1W
VOL (P < .001), with fair agreement between the two sequences (weighted 𝜅 = 0.35). Excluding a
mild reduction in lesion intensity in three dogs precontrast on the T1WVOL images compared to
T1W SE, and meningeal enhancement noted on the T1W VOL images in one dog, not identified
on T1WSE, therewas otherwise complete agreement between the two sequences. The T1WVOL
sequence provided equivalent lesion evaluation and significantly improved GWMdifferentiation.
Images acquired were of comparable diagnostic quality to those produced using a conventional
T1W SE technique, for assessment of lesion appearance, number, location, mass effect, and post-
contrast enhancement. T1W VOL, therefore, provides a suitable alternative T1W sequence for
canine brain evaluation and can facilitate a reduction in total image acquisition time.
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1 INTRODUCTION
Magnetic resonance imaging is the modality of choice for imaging the
canine brain, since it provides excellent tissue contrast resolution and
anatomic detail in addition to multiplanar image acquisition, without
the use of ionizing radiation.1–3 Increased caseloads have driven the
need to acquire high-quality images more rapidly. Shorter scan times
facilitate a higher case throughput, but are also advantageous to the
patient as the duration of anesthesia is reduced.
Abbreviations: 2D, two-dimensional; 3D, three-dimensional; CSF, cerebrospinal fluid; FLASH, fast low-angle shot; GE, gradient echo; GWM, grey-white matter; MP-RAGE, magnetisation
prepared rapid acquisition gradient echo;MPR, multiplanar reconstruction;MRI, magnetic resonance imaging; SE, spin echo; SNR, signal-to-noise ratio; TE, time to echo; TR, repetition time; T1W,
T1-weighted; T2W, T2-weighted; VOL, volumetric imaging.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in anymedium, provided
the original work is properly cited.
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Traditionally, SE sequences have been used to acquire two-
dimensional (2D), cross-sectional images of the canine brain. Gra-
dient echo (GE) sequences typically use smaller flip angles than SE
sequences (<90◦) and a gradient to rephase the spins, rather than a
180◦ radiofrequency pulse. Use of a gradient increases the speed of
rephasing, and smaller flip angles mean less time is required for relax-
ation; both strategies permit a shorter time to echo (TE) and repeti-
tion time (TR) than in SE, thus allowing studies to be performed more
rapidly.4 Relatively short acquisition times permit the use of GE for
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three-dimensional (3D) acquisition, also known as volumetric imaging
(VOL). This is the simultaneous acquisition of data from an entire vol-
ume of tissue, in a single acquisition using a nonselective excitation
pulse.5–8 Use of GE to acquire VOL images of the brain has been fre-
quently described in the human literature.7,9–13
Spoiled GE sequences, for example, a fast low-angle shot (FLASH)
sequence, can beused to generate T1WVOL images,with good tempo-
ral and spatial resolution.4,6,7 Spoiled gradient echouses a steady state,
by using a very short TR and amedium flip angle, and a short TE tomin-
imize T2* effects.4 T1W VOL images are acquired in very thin slices
(<1 mm) ideally with isotropic voxels, without a slice gap, that allow
image reformatting so that the voxels can be displayed as a newmatrix
of pixelswithout lossof spatial resolution.5,6,14 Therefore, onlyonevol-
umetric acquisition is required, but images can be reformatted to allow
assessment of transverse, sagittal, or dorsal planes,5,6,15 reducing total
image acquisition time compared to acquiring 2D images in all three
planes.16
In this study, we evaluate the use of a T1W VOL sequence com-
pared to a conventional T1W SE sequence, for the routine assessment
of canine brains. The appearance of lesions, enhancement, and grey-
white matter differentiation are appraised. The authors hypothesized
that there would not be a significant difference identified between the
two sequences and that T1W VOL imaging could be used in place of
conventional T1W SEMRI, for routine canine brain imaging, providing
equivalent lesion evaluation, while enabling a reduction in acquisition
time.
2 MATERIALS AND METHODS
This was a retrospective, observational study. Ethical approval was
granted by the Animal Welfare and Ethical Review Body of the Uni-
versity of Bristol. Dogs were selected from cases presented to the
Small Animal Hospital, University of Bristol, between December 2015
and July 2016, by a radiology resident (K.L.F.). For inclusion, patients
needed to have undergone MRI to further investigate clinical signs
referable to the brain, with acquisition of T1W SE and T1W VOL
sequences of the brain, pre- and postcontrast. Patients were excluded
if there was an absence of one or more of the required sequences,
if they previously had a brain MRI, if the source of clinical signs was
found to be extracranial, or if no clinical diagnosis was recorded, in an
attempt tominimize the potential for inaccurate classification of cases.
Patient data collected included the following: breed, age, sex, pre-
senting complaint, and clinical diagnosis. As part of the inclusion crite-
ria, all imaging was performed with a 1.5T MRI unit (Magnetom Sym-
phony, Siemens, Erlangen, Germany). A single channel head coil was
used as a receiver coil. All dogs were positioned in dorsal recumbency
under general anesthesia. All studies included the following sequences:
T1W SE images in transverse, T1W VOL images in dorsal, and post-
contrast T1W SE images and T1W VOL sequences acquired in the
same planes as precontrast. Additional sequences routinely acquired
includedaT2-weighted (T2W) sagittal and transverse, T2WFLAIR, and
T2*W images.
Transverse images (T1W VOL reformatted by multiplanar
reconstruction (MPR)), of each sequence were reviewed by one,
board-certified veterinary radiologist (C.W.S.) using DICOM viewer
freeware (Horos, v2.0.1; The Horos Project; www.horosproject.org).
The reviewer was blinded to the history, patient signalment, and clin-
ical or neurological examination findings. The cases were anonymized
and viewed in a randomized order. The T1W SE images were reviewed
separately to the T1W VOL images for each patient with the review
of all of the T1W SE images performed over approximately 7 days and
subsequently of the T1WVOL images over a similar time period. There
was an interval of greater than 7 days between review of the T1W SE
and the T1W VOL images. The image order was altered between the
two readings (initially by case number order and then by acquisition
date order). A standardized evaluation form was created for image
analysis. Several parameters were identified (by C.W.S. and K.L.F.),
which were considered important in the assessment of intracranial
lesions that could aid presumptive diagnosis. The reviewer subjectively
evaluated the images for: (a) lesion appearance precontrast (hyper-
intense, isointense, hypointense, or none seen); (b) number of lesions
(single or multiple); (c) lesion location (intra-axial or extra-axial); (d)
presence of mass effect (yes or no); (e) lesion enhancement postcon-
trast (homogeneous, heterogeneous, peripheral, or nonenhancing);
(f) grey-white matter (GWM) differentiation (minimal, moderate,
marked), and (g) presence of meningeal enhancement (yes or no).
With respect to the GWM differentiation, minimal was defined
as the following: no or very little difference in intensity between the
grey and white matter, with the two virtually isointense and margins
of the white matter hard to delineate. Moderate was defined as the
following: a subtle but discernible difference in intensity evident
between the grey and white matter, with white matter hyperintense
to grey matter, but the margins of the white matter still not clearly
defined at all times. Marked was defined as the following: a clear
difference in intensity between the grey and white matter, with white
matter obviously hyperintense to the grey matter and the margins of
white matter well defined.
For the purposes of evaluation, the cases were categorized
by the radiology resident (K.L.F.). Patients were grouped by their
presenting complaint: (a) ataxia (ataxia/circling/head tilt/gait alter-
ation/loss of balance); (b) seizures (or partial seizures); (c) weak-
ness/collapse/tremors; (d) facial nerve paralysis; (e) blindness, or (f)
other. The clinical diagnosis was recorded for each patient. Clinical
diagnosis was defined as: that reached after appraisal of the history,
neurological assessment, interpretation of all MRI sequences (not
just T1W) and any relevant clinical data (bloods, cerebrospinal fluid
(CSF) analysis, and where available histopathology), following the
exclusion of other disease processes. The diagnoses were grouped as:
(a) idiopathic; (b) neoplasia (eg, meningioma, glioma, choroid plexus
tumor); (c) inflammatory/infectious (eg, non-infectious inflammatory
meningoencephalitis (ie, granulomatous meningoencephalitis or
necrotizing encephalitis), or bacterial meningitis); (d) vascular (eg,
suspected cerebrovascular event/infarct or focal hemorrhage); (e)
congenital (eg, Chiari-like malformation or suspected epidermoid
cyst), or (f) degenerative/metabolic/toxic/nutritional.
FLEMING ET AL. 545
2.1 Statistical analysis
All statistical analyseswere performed using dedicated statistical soft-
ware (SPSS 20.0, SPSS Inc, Chicago, IL, USA) by an author experienced
in statistical analysis (T.W.M.). Independent variables were derived
from information obtained from the signalment data, presenting com-
plaints and clinical diagnosis. Descriptive statistics were generated for
all variables, with the categorical data amalgamated into appropriate
groups if required (due to small groups sizes) and expressed as fre-
quencies. Normality of distribution for age was also assessed via the
Kolmogorov-Smirnov and Shapiro-Wilk tests.
The primary outcome considered was the proportion of studies
identified as having marked GWM differentiation on the T1W SE
and T1W VOL sequences. A McNemar test for paired data was used
to evaluate differences in proportions between these sequences.
Weighted Kappa (𝜅w) was used to measure the degree of agreement
for GWM differentiation, where there were three ordinal categories.
Cohen’s Kappa (𝜅) was used as a standard measure of agreement
between the two sequences for the presence of meningeal enhance-
ment. Strength of agreement was evaluated according to the following
Kappa values: ≤0.2 poor, 0.21-0.4 fair, 0.41-0.6 moderate, 0.61-0.8
good, and 0.81-1.00 very good agreement. The percentage of cases
considered to be normal compared to those seen to have visible lesions
was also calculated. Results were considered significant if P< .05.
Sample size calculations indicated that to detect a minimum dif-
ference of 10% between the proportion of T1W SE versus T1W VOL
studies graded as having marked GWM distinction, with a power of
80% and a two-sided significance of 5% and allowing for correlation
of approximately 0.6 between paired observations, a minimum of 140
animals were required.
3 RESULTS
A total of 175 dogswere initially identified.Of these, 15were excluded
based on the previously detailed exclusion criteria. Thus, 160 dogs
were included in analyses for the current study. The study population
had a median age of 5 years (range 4 months to 14 years 10 months,
with an interquartile range of 2 years 10 months to 8 years 4 months).
There were 62 neutered females, 56 neutered males, 24 entire males,
and 18 entire females. Forty breeds were represented, the most com-
mon of which were: cross-breeds (28), Labradors (13), Boxers (10),
Cavalier King Charles Spaniels (8), Cocker Spaniels (8), Jack Russell
Terriers (8), French Bulldogs (7), and West Highland White Terriers
(7). The weights of the included patients ranged from 3.8 kg to 69 kg
(median weight= 18 kg).
Imaging parameters were tailored to each patient. The T1W SE
images were acquired in a transverse plane; TR was between 376-
771ms and TE was 10ms. Slice thickness was 2.5-3 mm in most cases,
but was typically reduced to 2 mm in patients <10 kg, with an inter-
slice gap of ≤0.9 mm. The acquisition time was approximately 3 min
30 s (range 3-4 min). For the T1W VOL images, a FLASH sequence
with chemical fat suppression was used. Images were acquired in a
dorsal plane with a TR of 20 ms, TE of 9.53 ms, and a flip angle of
25◦. The isotropic voxel size was 0.7-0.9 mm depending on the patient
size. The acquisition time was approximately 6 min 20 s (range 6-7
min). The postcontrast sequences were usually run within 1 min of
an intravenous bolus of 0.1 mmol/kg gadobenate dimeglumine (Mul-
tiHance 0.5 M, Bracco Imaging spa, Milan, Italy); individual varia-
tions in exact timing of the postcontrast image acquisition occurred
due to anesthesia staff occasionally performing patient checks or
adjusting equipment settings. The imaging parameters were kept the
same, with T1 VOL images acquired first, immediately followed by the
T1WSE.
The details of the patients’ presenting complaint/clinical signs and
the clinical diagnoses are summarized in Tables 1 and 2. A summary of
theMRI findings based on separate evaluation of the T1WSE andT1W
VOL images is shown in Table 3. The percentage agreement between
the two sequences is also detailed.
The most notable difference identified between the two sequences
was the GWM differentiation. One hundred ten of 160 patients
(68.7%) showedmarkedGWMdifferentiation on the T1WVOL images
in contrast to only 21/160 (13.1%) classified as marked on the T1W
SE images. The T1W VOL sequence enabled significantly better dif-
ferentiation of the grey and white matter than the T1W SE sequence
(P < .001). Agreement between the two sequences for GWM differ-
entiation was fair (weighted 𝜅 = 0.35). Only three of 160 patients
(1.9%) had minimal GWM differentiation on the T1WVOL sequences;
whereas with the T1W SE sequence 18/160 (11.3%) were classified as
minimal.With the T1WSE sequence, themajority of patients, 121/160
(75.6%) exhibited moderate GWM differentiation. Examples of differ-
ent GWMdifferentiation are shown in Figure 1. An example of the dif-
ference seen in GWM differentiation between the two sequences is
shown in Figure 2.
On both the T1W SE and T1W VOL sequences 29/160 patients
(18.1%) had lesions identified. The remaining 131/160 (81.9%) had no
lesion identifiedpre- or postcontrastwitheither sequence (ie, thebrain
was considered normal).With the T1WSE precontrast, three patients’
lesions were classified as hyperintense, seven as isointense, and 19 as
hypointense. Assessment of the T1W VOL images precontrast identi-
fied two patients with lesions that were classified as hyperintense, six
as isointense, and 21 as hypointense. There were two of three cases in
agreement between the two sequences for the hyperintense classifi-
cation, five of eight for isointense, and 19/21 in agreement classified as
hypointense.
Twenty-nine of 160 patients had lesions identified, all visible on
both sequences. No differences were identified between the two
sequences for determination of the number of lesions (single or mul-
tiple), the assessment of the lesion location, the presence of a mass
effect, or the enhancement pattern. Both the T1W SE and T1W VOL
identified 22/29 patients (75.9%) with single lesions and seven of 29
(24.1%) with multiple lesions. The lesion location was shown to be
intra-axial in 24/29 (82.8%) of the patients on both sequences and
extra-axial in five of 29 (17.2%) patients. Amass effectwas identified in
22/29 dogs (75.9%) on both the T1W SE and T1WVOL sequences and
was absent in seven of 29 (24.1%) dogs. Contrast enhancement was
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TABLE 1 The patients’ main presenting complaint/clinical sign, as detailed in the clinical records
Main presenting complaint/clinical sign Number of patients Percentage (%)
Seizures/partial seizures 71 44.4
Ataxia/circling/head tilt/gait alteration/loss of balance 40 25.0
Other 29 18.1
Weakness/collapse/tremors 13 8.1
Blindness 5 3.1
Facial nerve paralysis 2 1.3
160 100.0
TABLE 2 The clinical diagnosis for each patient, as detailed in the patient records
Clinical diagnosis classification Number of patients Percentage (%)
Idiopathic 66 41.3
Inflammatory/infectious 27 16.9
Other (including: movement disorder, endocrinopathy, open) 26 16.3
Neoplasia 23 14.4
Vascular 8 5.0
Congenital 5 3.1
Degenerative/metabolic/toxic/nutritional 5 3.1
Total 160 100.0
The clinical diagnosis was defined as: that reached after appraisal of the history, neurological assessment, interpretation of all MRI sequences (not just
T1W) and any relevant clinical data (bloods, cerebrospinal fluid (CSF) analysis and where available histopathology), following the exclusion of other disease
processes.
heterogeneous in 11/29 (37.9%), homogeneous in eight of 29 (27.6%),
and peripheral in six of 29 (20.7%), while four of 29 (13.8%) of the
patients’ lesions were noncontrast enhancing.
A high level of agreement for presence or absence of meningeal
enhancement was demonstrated between the two sequences
(𝜅 = 0.906). Therewas nomeningeal enhancement in 155/160 (96.9%)
of patients on the T1 SE and 154/160 patients (96.3%) on T1W VOL
sequence. Meningeal enhancement was present in both sequences in
five of 160 (3.1%) and seen on T1W VOL imaging only in just one of
160 (0.06%) patients.
Discounting the GWM differentiation, only four of 160 patients
showed a lack of agreement between the T1W SE and T1W VOL
sequences. In three out of four of these patients, the precontrast
relative signal intensity was lower on T1W VOL than T1W SE. In one
patient, the lesion altered from hyperintense on T1W SE to isointense
on T1W VOL (a 3-year-old male neutered Boxer, with a hemorrhagic
infarct in the right olfactory lobe, diagnosed with Angiostrongylus
vasorum). In two other patients, there was a change in classification
from iso- to hypointense, when evaluated on the T1W VOL sequence
instead of the T1W SE sequence (an 8-year-old female neutered Cav-
alier King Charles Spaniel, with a mass in the left cerebral hemisphere,
most likely a neoplastic metastasis from previous mammary neoplasia
(see Figure 3); also a 13-year-old female neutered Patterdale Terrier
cross, with a hemorrhagic mass lesion within the right forebrain). The
fourth patient was a 5-year-old female neutered Lurcher presented
for blindness. She was found to have a single, intra-axial, right parietal
lobe hemorrhagic mass lesion, thought most likely to be neoplastic;
it was hyperechoic precontrast, heterogeneously enhancing postcon-
trast, exerting a mass effect on both sequences. The inconsistency
between the two sequences was the meningeal enhancement (of the
pachymeninges) recorded as absent on the T1W SE sequence, yet
present on the T1WVOL. (see Figure 4).
4 DISCUSSION
The findings of our study demonstrated that the T1W VOL sequence
provided equivalent lesion evaluation to T1W SE imaging, for
assessment of lesion appearance and enhancement. Additionally,
significantly improved GWM differentiation was identified with the
T1W VOL images compared to T1W SE. As hypothesized T1W VOL
imaging can, therefore, provide a suitable alternative to conventional
T1WSEMRI, for routine evaluation of the canine brain.
Volumetric imaging has several advantages over conventional 2D
imaging.5–8 The slice thickness can be much less than in conven-
tional imaging, ≤0.9 mm in this study compared to 2-3 mm for the
SE sequence, permitting high spatial resolution. Thinner slices and the
lack of slice gap can lessen the likelihood of very small lesions being
missed, and reduce partial volume effects. In 2D imaging, where acqui-
sition is performed one slice at a time, slice thickness will affect the
signal-to-noise ratio (SNR). In VOL, data are acquired simultaneously
from an entire volume of tissue in a single acquisition and divided into
slices by a slice select gradient, in a process known as slice encoding.4
FLEMING ET AL. 547
TABLE 3 Summarized findings for each sequence showing the number (n)* and percentage (%) of patients exhibiting each feature evaluated
and the number and percentage of patients in which there was agreement between the T1WSE and T1WVOL sequences
T1WSE T1WVOL Sequences in agreement
n % n % n %
Normal brain 131/160 81.9 131/160 81.9 131/160 100
Abnormal brain 29/160 18.1 29/160 18.1 29/29 100
Lesion appearance (pre-contrast) Hyperintense 3/160 1.9 2/160 1.3 2/3 66.7
Isointense 7/160 4.4 6/160 3.7 5/8 62.5
Hypointense 19/160 11.9 21/160 13.1 19/21 90.5
None seen 131/160 81.9 131/160 81.9 131/131 100
Number of lesions Single 22/29 75.9 22/29 75.9 22/22 100
Multiple 7/29 24.1 7/29 24.1 7/7 100
Lesion location Intra-axial 24/29 82.8 24/29 82.8 24/24 100
Extra-axial 5/29 17 5/29 17.2 5/5 100
Presence of mass effect Yes 22/29 75.9 22/29 75.9 22/22 100
No 7/29 24.1 7/29 24.1 7/7 100
Enhancement (post-contrast) Homogeneous 8/29 27.6 8/29 27.6 8/8 100
Heterogeneous 11/29 37.9 11/29 37.9 11/11 100
Peripheral 6/29 20.7 6/29 20.7 6/6 100
Non-enhancing 4/29 13.8 4/29 13.8 4/4 100
GWMdifferentiation Marked 21/160 13.1 110/160 68.7 18/113 15.9
Moderate 121/160 75.6 47/160 29.4 32/136 23.5
Minimal 18/160 11.3 3/160 1.9 2/19 10.5
Meningeal enhancement Yes 5/160 3.1 6/160 3.7 5/6 83.3
No 155/160 96.9 154/160 96.3 154/155 99.4
*When considering each sequence: for features evaluated in all patients n= 160; for features that could only be evaluated when a lesion was present n= 29
(ie, representing the total number of patients where lesions were identified with each sequence).
F IGURE 1 Transverse T1-weighted SE (T1WSE) (A, B, and C) and T1-weighted volumetric (T1WVOL)MRI (D, E, and F). Examples of patients
subjectively classified as having either: marked (A andD), moderate (B and E), or minimal (C and F) grey-white-matter (GWM) differentiation
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F IGURE 2 TransverseMRI of a case with disparities identified in grey-white-matter differentiation between the two sequences. A,
T1-weighted spin echo imagewithminimal grey-white-matter differentiation and B, T1-weighted volumetric imagewithmarked
grey-white-matter differentiation. (A 1 year old, female entire, Staffordshire Bull Terrier, presented for seizures; MRI was unremarkable)
Since awhole volumeof tissue is excited and there are no gaps, the SNR
is increased.4 Additionally because thedata are collected froma slab of
tissue rather than a single slice, this can be reformatted using MPR to
allow assessment of the region of interest in any plane.5,6,10 The use
of small isotropic voxels (such as in this study) gives MPR’s with high
spatial resolution, which is equal regardless of plane.4,16 This allows
detailed evaluation of the brain andmay permit improved detection of
small intracranial lesions compared with 2D SE imaging.17–19 The use
of VOL imaging to acquire 3D data sets, negates the need for supple-
mental sequences in orthoganol imaging planes, reducing acquisition
time compared to acquisition of 2D images in all three planes.5–7,10,16
The T1W VOL sequence used in this study was a FLASH sequence,
the use of which has been described in the human literature to obtain
high resolution, very thin section, T1W images of the central nervous
system.6 This sequence takes advantage of excitation pulses with
small flip angles that speeds up acquisition time, by reducing the
time between successive TR, without sacrificing spatial resolution or
SNR.5,6,20 In contrast to SE, use of the low flip angle means much of
the longitudinal magnetization remains unaffected and thus is avail-
able for immediate subsequent excitations.20 FLASH images can be
acquired in 3D using a nonselective radiofrequency pulse and replac-
ing the slice selection gradient with an additional phase-encoding
F IGURE 3 Transverse T1-weighted spin echo (A) and T1-weighted volumetric (B)MRI from a patient where there was a difference in the
classification of the lesion intensity precontrast between the two sequences. A, On T1-weighted spin echo the lesion was classified as isointense.
B, On T1-weighted volumetric images the lesion was classified as hypointense
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F IGURE 4 Transverse T1-weighted spin echo (A) and T1-weighted volumetric (B)MRI demonstrating a disparity regarding the classification of
meningeal enhancement recorded in this patient. A, Absence of meningeal enhancement on T1-weighted spin echo. B, Subtle pachymeningeal
enhancement (indicated by arrows) associated with lesion, seen on T1-weighted volumetric image
gradient, perpendicular to the other gradients, which separates the
slices according to their phase value along the gradient.4,20 With 3D
imaging, data for thewhole region of interest are collected throughout
the image acquisition period.6
In this study, the T1W VOL sequence produced brain images with
significantly better GWM differentiation than the images acquired
using the T1WSE sequence (P< .001). Improved GWMdifferentiation
permits more detailed evaluation of the internal structure of the brain
andmay aid the localization and characterization of lesions/pathology,
especially those resulting in a reduction in normal GWM distinc-
tion. Evidence from the human literature corroborates our finding of
a superior GWM differentiation using a T1W VOL technique.6,7,9,12
The greater GWM differentiation results from stronger T1W contrast
achievedby theGE sequence.21 These studies all employ a short-TRGE
technique using a magnetization-preparation pulse (MP-RAGE), a 3D-
Turbo FLASH technique, to produce T1W images.21 No apparent dif-
ference in image quality was demonstrated between images acquired
using a 3D magnetisation prepared rapid acquisition gradient echo
(MP-RAGE) and 3D FLASH techniques in the study by Runge et al22
so the findings of these studies can be considered comparable to those
in our study.
Not only did our study demonstrate that GWM differentiation
was significantly better with the T1W VOL sequence, but also that
lesion identification was equivalent. There was 100% agreement
between the two sequences for identification of the presence of a
lesion, that is, 29/160 patients were found to have a lesion(s) on T1W
VOL and the same 29 had a lesion(s) identified on the T1W SE images.
Additionally, there was complete (100%) agreement between the two
sequences for classification of lesion number (single ormultiple), lesion
location (intra- or extra-axial), presence or absence of mass effect,
and the enhancement pattern postcontrast. This is consistent with
the findings of human studies that have demonstrated that T1 VOL
performs similarly to T1W SE for lesion detection in the brain.7,11,13
van den Hauwe et al7 reported that more lesions were identified
with T1W VOL imaging in both patients with neoplastic and non-
neoplastic disease, but no significant difference in lesion conspicuity
between gadolinium-enhanced MP-RAGE and T1W SE images was
found.
The degree of alteration in lesion precontrast signal intensity in
the three patients is likely to be inconsequential and would not be
expected to significantly alter the clinical diagnosis. It is postulated that
in two patients the reduction in intensity may be a result of the altered
appearance of hemorrhage on GE sequences compared to SE. In the
patient where a difference was noted in the presence of meningeal
enhancement, it is unclear which sequence is correct as neither CSF
analysis, nor histopathologywereperformed in this patient. Slice thick-
ness of the reformatted T1W VOL images is much thinner (0.75 mm)
so may have allowed the identification of a feature that was missed
on T1W SE images because of the thicker slices, (3 mm in this case).
Alternatively, it may be artifactual on the T1WVOL image, due to con-
trast enhancement of a meningeal blood vessel. Additionally, it should
be noted that the postcontrast VOL images were acquired before
the postcontrast T1 SE images, and it has been shown that increased
meningeal enhancement is seen immediately postcontrast compared
with delayed acquisition, in normal dogs.23
There is a paucity of veterinary studies looking at the use of 3D GE
in the clinical evaluation of canine brains. A previous study described
its use for evaluation of the pituitary gland in healthy dogs.15 Optimal
quality images were obtained with a T1W VOL sequence with a 1 mm
slice thickness and 30◦ flip angle, before and after intravenous injec-
tion of contrast medium; these parameters are similar to those used in
this study, with the exception that the study was conducted with a 0.2
Tesla openmagnet.15
Typical data acquisition time for the T1W VOL sequence (approx-
imately 6 min 20 s), was longer than the SE sequence (approximately
3 min 30 s). However, it is quicker than acquisition of multiple SE
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sequences in two planes, or the three planes that would be required
to provide equivalent information. In clinical practice, it is advised
that postcontrast T1W images are acquired in more than one plane.10
A time saving advantage can therefore be achieved using the T1W
VOL sequence since the capability for subsequent orthogonal image
reformatting improves acquisition efficiency.
There were several limitations to this study. Most notably, despite
the adequate overall sample size (160 patients), the proportion of
cases found to have lesions apparent on T1W imaging was relatively
low (29). With a lower prevalence of lesions within the sample popu-
lation, it is less likely that the findings would demonstrate differences
between the two sequences. There was complete agreement for
four of the seven parameters assessed, and the differences in lesion
intensity were insufficient in number to warrant statistical analy-
sis. Statistical analysis was performed to assess agreement for the
presence or absence of meningeal enhancement with a high level of
agreement demonstrated between the two sequences (𝜅 =0.906). This
is however unsurprising since a difference was only identified in one
case. Future studies could maximize the clinical information gained by
including a greater proportion of patients with lesions, by altering the
selection criteria. Secondly, assessment of the images in this studywas
subjective. Given the predominantly descriptive nature of the features
evaluated during this observational study, and absence of objective
parameters to assess, this may risk the introduction of slight observer
bias.
A definitive diagnosis was not reached in many of the cases due
to an absence of histopathological confirmation, and lack of relevant
blood (infectious disease serology) or CSF analysis results. It is gen-
erally accepted that definitive diagnosis is not possible on the basis
of MRI alone, because imaging features of neoplastic and certain
nonneoplastic diseases are not sufficiently specific.24,25 Histological
examination is typically required for definitive diagnosis of intracranial
neoplasms.26,27 Magnetic resonance imaging is however regularly
used for presumptive differentiation of neoplasia from inflammatory
disease, and to provide probable or prioritized differential diagnoses
to facilitate optimal patient management.24,25,28–30 During this study,
we evaluated MRI signs that have previously been identified as
being significantly associated with neoplasia, that is, a solitary lesion,
presence of mass effect and contrast enhancement,24 extra-axial
location,25 and those significantlymore commonly identified in inflam-
matory disease: meningeal enhancement andmultifocal lesions.25 The
aim of our study was however to evaluate agreement between the
two sequences for assessment of several important MRI features, to
determine whether a T1WVOL sequence could be used in place of the
conventional sequence, rather than to evaluate accuracy for reaching
a diagnosis. Additionally, the evaluation of T1W sequences alone,
precludes diagnosis; concurrent assessment of other weightings, for
example, T2W and FLAIR sequences, would typically be required
for comprehensive evaluation of all brain lesions. The collection and
inclusion of data regarding the clinical diagnosis for each patient
in this study was intended to summarize the characteristics of the
study population, rather than permit direct correlation with the study
findings.
Based on the findings of this study, the T1W VOL technique pro-
vided comparable lesion evaluation and significantly improved GWM
differentiation. The T1W VOL provided a suitable alternative T1W
sequence for the evaluation of dogs with suspected intracranial dis-
ease. Therefore, T1WVOL imaging could replace conventional T1WSE
for routine canine brain imaging, providing equivalent lesion appraisal
and a reduction in total image acquisition time.
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